NEWS RELEASES

The information contained in each news release on this page was factually accurate on the date it was issued and posted. 

Sutro Achieves $10 Million Milestone Payment from Celgene

Sutro develops successful spray drying technology marking a major advancement in commercial-scale manufacturing capabilities SOUTH SAN FRANCISCO, Calif., Dec. 19, 2018 -- Sutro Biopharma, Inc. (NASDAQ: STRO), today announced that the company earned $10 million in a...

read more

Sutro Biopharma Reports Third Quarter 2018 Financial Results

-- STRO-001 Received Orphan Drug Designation for Treatment of Multiple Myeloma -- STRO-002 to Begin Phase 1 Trial for Patients with Ovarian and Endometrial Cancers in Early 2019 SOUTH SAN FRANCISCO, Calif., Nov. 14, 2018 – Sutro Biopharma, Inc. (NASDAQ: STRO), a...

read more